
51 - 200 employees
Founded 2006
🏥 Healthcare
💼 Consulting
🧬 Biotechnology
💰 $60M Post-IPO Equity - Zevra Therapeutics on 2024-08
Healthcare • Consulting • Biotechnology
Zevra Therapeutics is a purpose-driven biopharmaceutical company focused on developing and delivering life-changing therapeutics for people living with rare diseases. The company advances treatments for conditions such as Niemann-Pick disease type C, urea cycle disorders, and vascular Ehlers–Danlos through clinical trials, expanded access programs, and marketed products (including MIPLYFFA® and OLPRUVA®). Zevra emphasizes patient and caregiver partnerships, regulatory and investor communications, and building a pipeline of rare-disease therapies.
📡 We watch Zevra Therapeutics's careers page
Several times a day
how often we check
1
roles posted in the last 30 days
2
roles closed in the last year
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 October 29
Field-based Senior/Principal MSL advancing Zevra Therapeutics’ rare disease portfolio across the Central U.S. Building scientific relationships and capturing insights for medical strategy.
🌽 Illinois, Iowa, +9 more states – Remote
💰 $60M Post-IPO Equity - Zevra Therapeutics on 2024-08
⏰ Full Time
🟠 Senior
👻 Ghost score 12%
🕒 June 24
Medical Science Liaison at Zevra Therapeutics engaging with healthcare professionals on rare diseases. Building relationships and providing scientific expertise to improve patient outcomes in the U.S.
🏈 Alabama, Colorado, +7 more states – Remote
💰 $60M Post-IPO Equity - Zevra Therapeutics on 2024-08
⏰ Full Time
🟠 Senior
👻 Ghost score 53%